APOLLOMICS INC. ANNOUNCES OFFICIAL OPENING OF SHANGHAI BRANCH
May 20, 2021 13:36 HKT |  |
|
USFDA recognized Antrodia cinnamomea mycelia (NDIN No.1170)
May 20, 2021 06:00 HKT |  |
|
Avance Clinical Expands Gene Technology Clinical Trial Services to Meet $17.4 billion Market Demand
May 07, 2021 00:00 HKT |  |
|
Scivita Medical Raises Nearly RMB0.4 Billion in Series A Funding Round and Strives to Build A World-leading Platform for Innovative Products in Endoscope and Related Fields
Apr 26, 2021 10:33 HKT |  |
|
Hua Medicine Announces Acceptance of a New Drug Application for Dorzagliatin in China - First Glucokinase Activator (GKA) Globally
Apr 23, 2021 14:06 HKT |  |
|
Avance Clinical Invited to Present "Decentralized Trials - No Going Back" for Oracle Health Sciences Connect
Apr 22, 2021 12:00 HKT | |
|
Agilex Biolabs acquires leading biolab TetraQ for APAC Expansion Plans
Apr 07, 2021 15:00 HKT |  |
|
Avantor Named Best Bioprocessing Supplier in Single-Use Manufacturing at Asia-Pacific Bioprocessing Excellence Awards 2021
Apr 06, 2021 13:29 HKT |  |
|
Viva Biotech Announced 2020 Annual Results
Mar 31, 2021 07:05 HKT |  |
|
TOT BIOPHARM Announces A Number of Key Anti-Tumor Drugs Have Entered the Pivotal Clinical Stage in 2020
Mar 24, 2021 07:35 HKT |  |
|
TrialWire launches StudyBoost, the Clinical Trial Insurance Plan
Mar 24, 2021 05:00 HKT |  |
|
Sino Biopharmaceutical 2020 Net Profit Grows to RMB2.77 Billion amid Adversity
Mar 23, 2021 17:09 HKT |  |
|
Ocumension Therapeutics (1477.HK) Announces 2020 Annual Results
Mar 20, 2021 10:10 HKT |  |
|
Milestone Development Achieved in Clinical Trials and Commercialization, Hua Medicine's Dorzagliatin Readying for NDA Submission
Mar 19, 2021 14:34 HKT | |
|
Alvotech Completes Second Round of a US$100 Million Private Placement
Mar 15, 2021 17:38 HKT |  |
|
Size matters: Bimodal imaging receives nanoparticle enhancement
Mar 10, 2021 20:00 HKT |  |
|
Apollomics, Inc. Appoints Seasoned Healthcare Executive K. Peony Yu, M.D., as Chief Medical Officer
Mar 09, 2021 10:35 HKT | |
|
Apollomics, Inc Announces Enrollment of First Patient in Phase 1 Clinical Trial of APL-106 (uproleselan injection) in China
Mar 04, 2021 11:30 HKT | |
|
Alvotech and Cipla Gulf Expand Partnership for Commercialization of Biosimilars in Australia and New Zealand
Mar 04, 2021 10:26 HKT | |
|
Maculus Therapeutix welcomes Privity, Prepares Capital Raise for Novel Drug Delivery Platform
Feb 19, 2021 07:00 HKT |  |
|